EARLY-PREG: Mapping maternal–embryo molecular communication before and after conception
Official title: EARLY-PREG: A Preconception, Longitudinal, Bidirectional, and Counterfactual Cohort Study of Women Seeking Pregnancy, Designed to Investigate Maternal-Embryonic Molecular Interactions During the Peri-implantation Window
Run by MELISA Institute Genomics & Proteomics Research SpA · NCT07358026 · Data updated 2026-11-12
This project will test whether patterns of proteins and other molecules in maternal fluids change in the first two weeks after fertilization in healthy women trying to conceive and in women not seeking pregnancy.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 40 Years |
| Sex | Women only |
| Enrollment | 223 (estimated) |
| Sponsor | MELISA Institute Genomics & Proteomics Research SpA Industry-sponsored |
| Locations | 1 site (Chiguayante) |
| Status | Recruiting |
| Started | July 11, 2017 |
| Main results expected | December 2026 |
| Study ends | December 2027 |
| Registry record updated | April 29, 2026 |
| Trial ID | NCT07358026 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Healthy women aged 18–40 with regular menstrual cycles and BMI 18–29 who are not currently pregnant, including those trying to conceive with a healthy male partner or women not seeking pregnancy, are ideal candidates.
✕Probably not a fit
People with chronic diseases, known fertility disorders, prior pelvic disease or surgery, allergy to study materials, or those undergoing infertility treatments are unlikely to benefit from or be eligible for this cohort focused on spontaneous conception.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
EARLY-PREG is an open preconception cohort using a counterfactual design that follows healthy women from before conception through the first two weeks after fertilization, with continued follow-up into pregnancy and childbirth. Participants provide daily biosamples (saliva, urine, blood, cervicovaginal fluid and brushings) during key cycle phases; samples are processed and stored in a growing biorepository for proteomic analysis. The cohort compares menstrual cycles that result in full-term live birth, early pregnancy loss, or no pregnancy to identify molecular signatures of embryo–maternal crosstalk. The longitudinal, bidirectional approach aims to link early molecular changes to later clinical outcomes of spontaneous conception.
Why it matters
Potential benefit: If successful, this work could identify early molecular markers that predict whether a conception will progress to full-term pregnancy or result in early loss, enabling earlier counseling and focused research on interventions.
How similar studies have gone: Animal and in vitro work supports embryo–maternal signaling and small human proteomic studies suggest informative markers, but a preconception, counterfactual in vivo human cohort like EARLY-PREG is largely novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria: * being between 18 and 40 years of age * not being pregnant * normal colposcopy * body mass index (BMI) between 18 and 29 * regular menstrual cycles (21-35 days) * absence of chronic diseases (hypertension, diabetes mellitus, cancer, depression, personality disorder, thyroid pathology, polycystic ovary syndrome, or hyperprolactinemia). * If seeking pregnancy, they were included if their partners were males between 18 and 40 years old, without pathologies (diabetes mellitus, depression, personality disorder, or cancer), were not taking chronic medication, without erectile disorders, BMI between 18 and 29.9, moderate alcohol use, and with no recreational drug use. Exclusion criteria: * pregnant women * history of alcoholism * infertility treatment * endometriosis * pelvic inflammatory disease * pelvic surgery * allergy to latex or silicone * If seeking pregnancy, they were excluded if their partners were working in contact with pesticides, or with history of erectile dysfunction, or history of mumps in adulthood, or with chronic diseases, or with psychological problems.
Where it's running
-
Clínica Sanatorio Alemán
Chiguayante, Chile Recruiting
Study contacts
- Study coordinator: Elard S Koch
- Email: ekoch@melisainstitute.org
- Phone: +56 41 246 7242
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Comparing high-intensity and moderate-intensity exercise during pregnancy and its effects on health and birth outcomes
This study tests whether high-intensity or moderate-intensity exercise during pregnancy can improve health and birth outcomes for moms and their babies.
-
Pregnant Women Living with HIV on Bictegravir/Emtricitabine/Tenofovir Alafenamide
This study looks at how B/F/TAF is used in pregnant women with HIV and whether it helps maintain viral suppression from before conception through delivery.
-
Pelvic Floor Training and a Modified Lumbopelvic Belt for Symphysis Pubis Pain in Pregnancy
This study tests whether pelvic floor muscle training plus a modified lumbopelvic belt can reduce pain and improve function for pregnant women with symphysis pubis pain.
-
Effective Communication in VBAC Counseling
This study tests how clearly doctors and midwives explain VBAC options during prenatal visits and whether patients feel understood.
-
Innovative Multidisciplinary and Virtual Care for IBD in Pregnancy
This study tests a dedicated IBD pregnancy care model, including a new virtual approach, to see if it improves access and quality of care for pregnant people with Crohn's disease or ulcerative colitis.
-
Compare spinal-epidural versus general anesthesia for babies after cesarean delivery
This trial tests whether the type of anesthesia used for cesarean delivery affects newborn hearing in babies.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.